|
|
|
|
 |
| Strides Pharma Science Ltd |
Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
|
| BSE Code |
|
| 532531 |
|
|
|
| ISIN Demat |
|
| INE939A01011 |
|
|
|
| Book Value |
|
| 376.844232 |
|
|
|
| Mar.Cap(Rs.Cr) |
|
| 8,118.88 |
|
|
|
| P/E |
|
| 92.70 |
|
|
|
| Face Value |
|
| 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High(Rs) |
Low(Rs) |
Close(Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs. In Cr.) |
| Apr 2024 |
911.95 |
798.00 |
896.45 |
405.99 |
347.07 |
392.30 |
8,238.35 |
| Mar 2024 |
834.00 |
720.10 |
782.60 |
376.44 |
287.54 |
342.48 |
7,192.07 |
| Feb 2024 |
838.10 |
685.20 |
787.60 |
374.25 |
296.61 |
344.67 |
7,238.02 |
| Jan 2024 |
735.20 |
644.50 |
698.20 |
332.94 |
271.07 |
305.54 |
6,416.44 |
| Share Prices Of
2023
|
| Dec 2023 |
665.10 |
482.50 |
648.40 |
295.50 |
209.90 |
283.71 |
5,957.87 |
| Nov 2023 |
512.00 |
467.40 |
486.60 |
228.58 |
197.70 |
212.91 |
4,471.16 |
| Oct 2023 |
528.25 |
469.95 |
476.60 |
233.69 |
203.02 |
208.54 |
4,379.27 |
| Sep 2023 |
549.00 |
433.80 |
508.10 |
242.04 |
185.02 |
218.56 |
4,589.81 |
| Aug 2023 |
488.85 |
412.45 |
442.75 |
214.07 |
176.58 |
190.45 |
3,999.49 |
| Jul 2023 |
486.80 |
432.00 |
472.10 |
210.78 |
184.14 |
203.08 |
4,264.61 |
| Jun 2023 |
441.20 |
353.50 |
430.25 |
194.98 |
149.47 |
185.01 |
3,885.27 |
| May 2023 |
390.00 |
330.35 |
360.15 |
180.25 |
138.70 |
154.87 |
3,252.25 |
| Apr 2023 |
343.25 |
287.90 |
340.55 |
150.32 |
118.14 |
146.44 |
3,075.26 |
| Mar 2023 |
301.15 |
268.40 |
286.15 |
131.57 |
113.35 |
123.05 |
2,584.01 |
| Feb 2023 |
309.80 |
281.45 |
297.80 |
16.38 |
14.30 |
15.28 |
2,689.21 |
| Jan 2023 |
372.90 |
292.50 |
295.35 |
19.56 |
14.87 |
15.16 |
2,667.09 |
| Share Prices Of
2022
|
| Dec 2022 |
392.20 |
336.95 |
349.05 |
21.67 |
17.00 |
17.91 |
3,152.02 |
| Nov 2022 |
357.00 |
309.25 |
336.85 |
18.96 |
15.58 |
17.29 |
3,041.85 |
| Oct 2022 |
348.40 |
287.30 |
309.45 |
18.09 |
14.70 |
15.88 |
2,794.03 |
| Sep 2022 |
340.00 |
303.65 |
332.70 |
17.50 |
14.82 |
17.07 |
3,003.96 |
| Prev |
Next
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|